NIT
ISEE

NumerixS Investment Technologies’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

NumerixS Investment Technologies’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,400
Closed -$53K – 1402
2017
Q1 		$53K Buy
+14,400
New +$60.9K 0.01% 1006
2016
Q4 		– Sell
-8,300
Closed -$383K – 1381
2016
Q3 		$383K Sell
8,300
-1,000
-11% -$56.4K 0.05% 458
2016
Q2 		$475K Buy
+9,300
New +$462K 0.07% 412

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NumerixS Investment Technologies's ISEE Position: Q2 2017 in Review

NumerixS Investment Technologies sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 14,400 shares — an estimated $53K sold.

NumerixS Investment Technologies first reported a position in ISEE in Q2 2016 and held it in 3 quarters. The position peaked at $475K in Q2 2016. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • NumerixS Investment Technologies reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • NumerixS Investment Technologies sold 14,400 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $53K.
  • NumerixS Investment Technologies first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
  • NumerixS Investment Technologies's IVERIC bio, Inc. Common Stock position peaked at $475K in Q2 2016.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on NumerixS Investment Technologies's 13F filing for Q2 2017, filed 9 Aug 2017.